Endoscopic Ultrasound-guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial.

Published on Jun 8, 2021in Gastroenterology17.373
· DOI :10.1053/J.GASTRO.2021.06.005
Stefano Francesco Crinò14
Estimated H-index: 14
,
Roberto Di Mitri11
Estimated H-index: 11
+ 45 AuthorsGloria Fernández-Esparrach33
Estimated H-index: 33
(University of Barcelona)
Sources
Abstract
ABSTRACT null null Background and aims null Benefit of rapid on-site evaluation (ROSE) on diagnostic accuracy of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) has never been evaluated in a randomized study. This trial aimed to test the hypothesis that in solid pancreatic lesions (SPLs), diagnostic accuracy of EUS-FNB without ROSE was not inferior to that of EUS-FNB with ROSE. null null null Methods null Non-inferiority study (non-inferiority margin 5%) conducted at 14 centers in eight countries. Patients with SPLs requiring tissue sampling were randomly assigned (1:1) to undergo EUS-FNB with or without ROSE, using new generation FNB needles. The touch imprint cytology technique was used to perform ROSE. Primary endpoint was diagnostic accuracy. Secondary endpoints included safety, tissue core procurement, specimen quality, and sampling procedural time. null null null Results null Eight hundred patients were randomized over an 18-month period, and 771 analyzed (385 with ROSE and 386 without). Comparable diagnostic accuracies were obtained in both arms (96.4% with ROSE and 97.4% without ROSE, p=0.396). Non-inferiority of EUS-FNB without ROSE was confirmed with an absolute risk difference of 1.0% (two-sided 90% CI: -1.1% to 3.1%, pnon-inferiority null null null Conclusion null EUS-FNB demonstrated high diagnostic accuracy to evaluate SPLs independently on execution of ROSE. When new generation FNB needles are used, ROSE should not be routinely recommended. null ClinicalTrial.gov , number NCT03322592.
📖 Papers frequently viewed together
12 Citations
11 Citations
8 Citations
References47
Newest
#1Priscilla A. van Riet (Erasmus University Medical Center)H-Index: 5
#2Nicole S. Erler (EUR: Erasmus University Rotterdam)H-Index: 16
Last. Djuna L. Cahen (Erasmus University Medical Center)H-Index: 26
view all 4 authors...
BACKGROUND EUS-guided tissue acquisition is extensively used, but the optimal sampling device is still a matter of debate. We performed a meta-analysis on studies comparing FNA to FNB needles, in addition to a mutual comparison of FNB needles. METHODS Online databases were searched for randomized controlled studies of at least 50 cases with a suspected solid pancreatic or non-pancreatic lesion that compared FNA to FNB ProCore, SharkCore, or Acquire needles. Outcome measures included diagnostic a...
9 CitationsSource
#2Serena AmmendolaH-Index: 3
Last. Erminia ManfrinH-Index: 24
view all 16 authors...
Abstract Background/objectives Studies comparing EUS-guided fine-needle aspiration (EUS-FNA) with EUS-guided fine-needle biopsy (EUS-FNB) for the evaluation of pancreatic neuroendocrine tumors (pNETs) are lacking. We aimed at comparing EUS-FNA with EUS-FNB in terms of Ki-67 proliferative index (PI) estimation capability, cellularity of the samples, and reliability of Ki-67 PI/tumor grading compared with surgical specimens. Methods Patients diagnosed with pNETs on EUS and/or surgical specimens we...
4 CitationsSource
#1Yen-I Chen (MUHC: McGill University Health Centre)H-Index: 7
#1Yen-I. Chen (MUHC: McGill University Health Centre)H-Index: 1
Last. Clarence Wong (Alexandra Hospital)H-Index: 13
view all 28 authors...
BACKGROUND AND STUDY AIMS EUS-guided fine needle aspiration (EUS-FNA) is the standard in the diagnosis of pancreatic solid lesions, in particular when combined with rapid on-site evaluation of cytopathology (ROSE). More recently, a fork-tip needle for core biopsy (FNB) has been shown to be associated with excellent diagnostic yield. EUS-FNB alone; however, has not been compared to EUS-FNA+ROSE in a large clinical trial. Our aim is to compare EUS-FNB alone to EUS-FNA+ROSE in solid pancreatic lesi...
5 CitationsSource
Abstract Background and aims The aim of this study was to compare the performance of EUS-guided fine-needle biopsy using fork-tip (SharkCore, Medtronic, USA) or side-fenestrated (ProCore, Cook Medical, Limerick, Ireland) needles in patients with solid pancreatic lesions. Methods This is a randomized controlled study conducted in a single academic center, including patients who underwent sampling with the fork-tip or the side-fenestrated 22-gauge or 25-gauge needles. Three passes were performed, ...
16 CitationsSource
#1Ankit Chhoda (Yale University)H-Index: 5
#2Tarun Rustagi (UNM: University of New Mexico)H-Index: 22
Endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA), though a well-established method for specimen acquisition from pancreatic neoplasm, has a limited role for non-focal benign pancreatic diseases such as autoimmune pancreatitis (AIP) due to sample inadequacy and architectural distortion. Core biopsies through EUS-trucut biopsy (EUS-TCB) or newer generation EUS-fine needle biopsy (EUS-FNB) enable better histopathologic review through greater tissue specimen size and visualization of ...
3 CitationsSource
#1Megan J. Fitzpatrick (Harvard University)H-Index: 7
#2Yasmin G. Hernandez-Barco (Harvard University)H-Index: 3
Last. Martha B. Pitman (Harvard University)H-Index: 53
view all 5 authors...
Abstract Background Pancreatic endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) acquires both direct smear and small core biopsy specimens. Triage protocols for pancreatic FNBs to cytopathology (CP) or gastrointestinal surgical pathologist (GIP) is controversial and varies by institution. Material and Methods Pancreatic EUS-FNBs obtained with the SharkCoreTM FNB were reviewed between January 2014 and June 2019. Specimen characteristics and pathology data including tissue triage were obt...
1 CitationsSource
#1Hitomi Sakamoto (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 3
#2Marc A. Attiyeh (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 15
Last. Christine A. Iacobuzio-Donahue (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 55
view all 22 authors...
Surgery is the only curative option for Stage I/II pancreatic cancer, nonetheless most patients will recur after surgery and die of their disease. To identify novel opportunities for management of recurrent pancreatic cancer we performed whole exome or targeted sequencing of 10 resected primary cancers and matched intrapancreatic recurrences or distant metastases. We identified that recurrent disease after adjuvant or first-line platinum therapy corresponds to an increased mutational burden. Rec...
23 CitationsSource
#1Irene Y. Xie (U of T: University of Toronto)H-Index: 1
#2Steven Gallinger (OICR: Ontario Institute for Cancer Research)H-Index: 35
Last. Steven Gallinger (OICR: Ontario Institute for Cancer Research)H-Index: 109
view all 2 authors...
Most patients who undergo curative intent surgery for pancreatic cancer will still die of recurrent disease. A new study shows that pancreatic tumours that pass through the genetic bottlenecks of surgery and additional chemoradiotherapy have altered mutational signatures, driver genes and subclonal architecture.
2 CitationsSource
#1Diogo Turiani Hourneaux de Moura (USP: University of São Paulo)H-Index: 19
#2Thomas R. McCarty (Harvard University)H-Index: 22
Last. Christopher C. Thompson (Harvard University)H-Index: 59
view all 8 authors...
Background and study aims Endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) is traditionally considered a first-line strategy for diagnosing pancreatic lesions; however, given less than ideal accuracy rates, fine-needle biopsy (FNB) has been recently developed to yield histological tissue. The aim of this study was to compare diagnostic yield and safety between EUS-FNA and EUS-FNB in sampling of pancreatic masses. Patients and methods This was a multicenter retrospective study to e...
5 CitationsSource
#1David KarsentiH-Index: 6
#2Laurent PalazzoH-Index: 45
Last. Bertrand NapoleonH-Index: 28
view all 7 authors...
: BACKGROUND : Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) has been suggested for obtaining high quality tissue samples from pancreatic tumors. We performed a multicenter randomized crossover trial comparing EUS-FNB with a 20G Procore needle vs. a 22G Acquire needle. The aims were to compare the quantity of targeted tissue (pancreas) and diagnostic accuracy for the two needles. METHODS : 60 patients admitted for EUS-FNB in three endoscopy units were included. One pass was performed...
9 CitationsSource
Cited By2
Newest
#1Hyun Jin Park (UOU: University of Ulsan)
#2Jun Seong Hwang (Inje University)H-Index: 1
Last. Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
view all 9 authors...
Abstract null null Background null Retroperitoneal neurogenic tumors are extremely rare pathological entities; therefore, few clinical features and natural courses, especially originating from the pancreatic/peripancreatic regions, have been reported. This study aimed to investigate the clinicopathological features of pancreatic and peripancreatic neurogenic tumors and assess the diagnostic value of computed tomography (CT) and endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). null null...
Source
Beyond pancreatic ductal adenocarcinoma, which is by far the most frequent pancreatic neoplasm, a great variety of tumors occur in the pancreas. They include solid and cystic masses and epithelial and nonepithelial neoplasms, and they show a great diversity in their biological behavior, ranging from benign tumors to highly aggressive neoplasms. As examples of rare pancreatic tumors, clinical, morphological, and molecular aspects of acinar cell carcinoma, pancreatoblastoma, solid pseudopapillary ...
Source
#1Yuhei Iwasa (Gidai: Gifu University)H-Index: 4
#2Takuji Iwashita (Gidai: Gifu University)H-Index: 26
Last. Takeshi Hara (Gidai: Gifu University)H-Index: 37
view all 0 authors...
Background: Contrast-enhanced endoscopic ultrasound (CE-EUS) is useful for the differentiation of pancreatic tumors. Using deep learning for the segmentation and classification of pancreatic tumors might further improve the diagnostic capability of CE-EUS. Aims: The aim of this study was to evaluate the capability of deep learning for the automatic segmentation of pancreatic tumors on CE-EUS video images and possible factors affecting the automatic segmentation. Methods: This retrospective study...
Source
#1Antonio Facciorusso (University of Foggia)H-Index: 19
#2Daryl Ramai (Brooklyn Hospital Center)H-Index: 9
Last. Stefano Francesco CrinòH-Index: 14
view all 7 authors...
There is scarce and conflicting evidence on the comparison between endoscopic ultrasound (EUS) and percutaneous (PC)-guided liver biopsy (LB). The aim of this study was to compare the two approaches in a series of patients with parenchymal and focal liver lesions. Fifty-four patients undergoing EUS-LB in two high-volume centers between 2017 and 2021 were compared to 62 patients who underwent PC-LB. The primary outcome was diagnostic adequacy rate. The secondary outcomes were diagnostic accuracy,...
Source
Pancreatic neuroendocrine neoplasms (PanNENs) are relatively rare, but their incidence has increased significantly in the last decades. Precise diagnosis and prognostic stratification are crucial for proper patient management. Endoscopic ultrasound (EUS) is the modality of choice for diagnosis of solid pancreatic tumors, showing a higher tumor detection rate than other imaging modalities, especially for small size lesions. EUS also serves as a guide for preoperative sampling and other interventi...
Source